Axena Health’s Commitment to Women’s Health Extends to Low- and Middle-Income Countries​

In line with Axena Health’s commitment to women’s health, the company has established a workstream focused on lower- and middle-income countries (LMICs), aiming to develop a Leva-informed solution to address pelvic floor disorders among women in LMICs. This investment is aligned with UN Sustainable Development Goals

      1 – No Poverty,

     3 – Good Health & Well-Being,

     5 – Gender Equality, and

     10 – Reduced Inequalities. ​

The social mission of Axena Health is to provide all women with accessible and effective treatment to address their pelvic floor symptoms.​

​In 2023 Axena Health conducted a large-scale study to investigate the burdens of incontinence on women in low- and middle-income countries to support equitable access to treatment. The first-of-its-kind study examined how women could access treatment within local healthcare delivery systems and in a manner that accommodates cultural norms. Study results will inform the development of new treatment options based on the Leva® Pelvic Health System. ​

This research sought to understand and share healthcare workers’ (HCWs) perspectives on and women’s lived experiences with UI to direct actionable changes in awareness and treatment for this health condition. Research findings are summarized in two reports. The publicly available report, Urinary Incontinence in Sub-Saharan Africa: Experiences of Women and Healthcare Workers in Nigeria and Kenya and Opportunities for Expanding Care, provides an in-depth overview of the factors that drive healthcare decision-making and care-seeking and women’s and HCWs’ experience with UI, including effects on mental and physical health and quality of life and various aspects of UI treatment. ​

Related Information

For more information, contact Jessica McKinney, VP, Clinical Affairs and Global Health ([email protected]) or Laura Keyser, Director of Clinical Strategy and Global Health ([email protected])